SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  

Performance Acquisition Corp · S-1/A · On 2/29/08

Filed On 2/29/08 6:31pm ET   ·   SEC File 333-148367   ·   Accession Number 1193125-8-43989

  in   Show  and 
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

 3/03/08  Performance Acquisition Corp      S-1/A       2/29/08    2:135                                    RR Donnelley/FA

Pre-Effective Amendment to Registration Statement (General Form)   ·   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment No. 1 to Form S-1                         HTML    942K 
 2: EX-23.1     Consent of Experts or Counsel                       HTML      5K 


S-1/A   ·   Amendment No. 1 to Form S-1
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page
"Table of Contents
"Summary
"Risk Factors
"Cautionary Note Regarding Forward-Looking Statements
"Use of Proceeds
"Dividend Policy
"Dilution
"Capitalization
"Management s Discussion and Analysis of Financial Condition and Results of Operations
"Proposed Business
"Management
"Principal Stockholders
"Certain Relationships and Transactions with Related Persons, Promoters and Control Persons
"Description of Securities
"Material U.S. Federal Income Tax Consequences to U.S. Holders
"Material U.S. Federal Income Tax Consequences to Non-U.S. Holders
"Underwriting
"Legal Matters
"Experts
"Where You Can Find Additional Information
"Index to Financial Statements
"Report of independent registered public accounting firm
"Balance sheet as of November 30, 2007
"Statement of operations for the period October 24, 2007 (inception) through November 30, 2007
"Statement of stockholders equity for the period October 24, 2007 (inception) through November 30, 2007
"Statement of cash flows for the period October 24, 2007 (inception) through November 30, 2007
"Notes to financial statements

This is an EDGAR HTML document rendered as filed.  [ Alternative Formats ]


  Amendment No. 1 to Form S-1  
Table of Contents

As filed with the Securities and Exchange Commission on February 29, 2008

Registration No. 333-148367


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


AMENDMENT NO. 1

TO

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933


PERFORMANCE ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   6770   26-1304050

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

970 West Broadway

PMB 402

Jackson, Wyoming 83001

(307) 633-2831

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


Jonathan J. Ledecky, President and Secretary

Performance Acquisition Corp.

970 West Broadway

PMB 402

Jackson, Wyoming 83001

(307) 633-2831

(Name, address, including zip code, and telephone number, including area code, of agent for service)


Copies to:

 

David Alan Miller, Esq.

Jeffrey M. Gallant, Esq.

Graubard Miller

The Chrysler Building

405 Lexington Avenue

New York, New York 10174

(212) 818-8800

(212) 818-8881 - Facsimile

  

Bruce S. Mendelsohn, Esq.

Akin Gump Strauss Hauer & Feld LLP

590 Madison Avenue

New York, New York 10022

(212) 872-1000

(212) 872-1002 - Facsimile


Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 


 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 



Table of Contents

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED                     , 2008

 

P R O S P E C T U S

 

$500,000,000

 

Performance Acquisition Corp.

 

50,000,000 Units

 


 

Performance Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more operating businesses in the entertainment, media and/or publishing industry, which we refer to as our initial business combination. If we are unable to consummate a business combination within 24 months from the date of this prospectus, or 30 months from the date of this prospectus if a definitive agreement has been executed within 24 months after the date of this prospectus and the initial business combination has not yet been consummated within such 24-month period, we will liquidate and distribute the proceeds held in the trust account to our public stockholders. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We do not have any specific initial business combination under consideration. We have not, nor has anyone on our behalf, contacted or been contacted by any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction.

 

This is an initial public offering of our securities. Each unit consists of one share of common stock and one half of one redeemable common stock purchase warrant, which we refer to as a warrant throughout this prospectus. We are offering 50,000,000 units. The public offering price will be $10.00 per unit. Each whole warrant entitles the holder to purchase one share of common stock at a price of $5.50. The warrants will become exercisable on the later of the completion of our initial business combination and one year from the date of this prospectus, provided in each case that we have an effective registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to them is available. The warrants will expire five years from the date of this prospectus, unless earlier redeemed.

 

We have also granted the underwriters a 30-day option to purchase up to an additional 7,500,000 units to cover over-allotments, if any.

 

Eric J. Watson, our chairman of the board and treasurer, Jonathan J. Ledecky, our president and secretary, and William Morris Agency, LLC, an entity affiliated with John M. Mass, a director of ours, have agreed to purchase an aggregate of 5,000,000 warrants at a price of $1.00 per warrant ($5.0 million in the aggregate) in a private placement that will occur simultaneously with the consummation of this offering. We refer to these warrants as the “sponsors’ warrants.” The proceeds from the sale of the sponsors’ warrants in the private placement will be deposited into a trust account and be subject to a trust agreement, described below, and will be part of the funds distributed to our public stockholders in the event we are unable to complete a business combination. The sponsors’ warrants will be substantially similar to the warrants included in the units sold in this offering except that if we call the warrants for redemption, the sponsors’ warrants will be exercisable on a cashless basis at the election of the holder and will not be redeemable by us so long as they are still held by these purchasers or their affiliates. The purchasers of the sponsors’ warrants have agreed not to transfer, assign or sell any of these warrants until we consummate our initial business combination.

 

Currently, there is no public market for our units, common stock or warrants. We intend to apply to have the units listed on the American Stock Exchange. Assuming that the units are listed on the American Stock Exchange, the units will be listed under the symbol “            .U” on or promptly after the date of this prospectus. The common stock and warrants will begin separate trading on the 35th day after the date of this prospectus unless Citigroup Global Markets Inc. informs us of its decision to allow earlier separate trading. No fractional warrants will be issued and only whole warrants will trade. Once the securities comprising the units begin separate trading, the common stock and warrants will be traded on the American Stock Exchange under the symbols “            ” and “            .WS,” respectively. We cannot assure you, however, that our securities will continue to be listed on the American Stock Exchange.

 

Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 23 for a discussion of information that should be considered in connection with an investment in our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 


 

     Per Unit

   Total

Public Offering Price

   $ 10.00    $ 500,000,000

Underwriting Discount(1)

   $ 0.70    $ 35,000,000

Proceeds to Performance Acquisition Corp. (before expenses)

   $ 9.30    $ 465,000,000

(1)   Includes $0.40 per unit or $20.0 million in the aggregate ($23.0 million if the underwriters’ over-allotment option is exercised in full), payable to the underwriters for deferred underwriting discounts and commissions to be placed in the trust account described below. Such funds will be released to the underwriters only on completion of an initial business combination, as described in this prospectus.

 

The underwriters are offering the units on a firm commitment basis. The underwriters expect to deliver the units to purchasers on or about                     , 2008. Of the proceeds we receive from this offering and the sale of the sponsors’ warrants described in this prospectus, approximately $9.79 per share, or $489,250,000 in the aggregate (approximately $9.77 per share, or $562,000,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), will be deposited into a trust account, at JPMorgan Chase NY Bank, with Continental Stock Transfer & Trust Company as trustee. These funds will not be released until the earlier of the completion of our initial business combination and our liquidation (which may not occur until 24 months from the date of this prospectus or 30 months under certain circumstances).

 


Citi

 


The date of this prospectus is                     , 2008


Table of Contents

 TABLE OF CONTENTS

 

     Page

Summary

   1

Risk Factors

   23

Cautionary Note Regarding Forward-Looking Statements

   45

Use of Proceeds

   46

Dividend Policy

   50

Dilution

   51

Capitalization

   53

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   54

Proposed Business

   58

Management

   78

Principal Stockholders

   93

Certain Relationships and Transactions with Related Persons, Promoters and Control Persons

   96

Description of Securities

   99

Material U.S. Federal Income Tax Consequences to U.S. Holders

   107

Material U.S. Federal Income Tax Consequences to Non-U.S. Holders

   111

Underwriting

   114

Legal Matters

   118

Experts

   118

Where You Can Find Additional Information

   119

Index to Financial Statements

   F-1

 

Until                                 , 2008 (25 days after the date of this prospectus), all dealers that buy, sell or trade our securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

 

i


Table of Contents

 SUMMARY

 

This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under “Risk Factors” beginning on page 23 of this prospectus and our financial statements and the related notes included elsewhere in this prospectus, before investing. References in this prospectus to “we,” “us” or our company refer to Performance Acquisition Corp. References in this prospectus to “public stockholders” refer to those persons that purchase the securities offered by this prospectus, including any of our officers, directors and founders (as defined below) who purchase these securities, either in this offering or afterwards, provided that such individuals’ status as “public stockholders” shall only exist with respect to those securities so purchased. References in this prospectus to our “management team” refer to our officers and directors. Unless we tell you otherwise, the information in this prospectus assumes that the underwriters will not exercise their over-allotment option and an aggregate of 1,875,000 founders’ units, representing 1,875,000 shares of founders’ common stock and 937,500 founders’ warrants, have been forfeited by our founders.

 

We are a blank check company formed under the laws of the State of Delaware on October 24, 2007. We were formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase reorganization or similar business combination with a currently unidentified operating business or several operating businesses in the entertainment, media and/or publishing industry, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not, nor has anyone on our behalf (including William Morris Agency, LLC), contacted or been contacted by any potential target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. Additionally, we have neither engaged nor retained any agent or other representative, including William Morris Agency, LLC, to conduct any research or take any steps to identify, locate or contact any suitable acquisition candidate.

 

The entertainment, media and/or publishing industry encompasses those companies which create, produce, deliver, own, distribute and/or market entertainment and information content, products and services. These companies serve both domestic and international audiences. The media and entertainment industry represents a large and expanding segment of the United States economy. According to PricewaterhouseCoopers, LLP, global media and entertainment industry spending reached $1.4 trillion in 2006 and is expected to increase to $2.0 trillion in 2011. The United States marketplace accounts for $582 billion, or 41%, of the $1.4 trillion in spending.

 

Growth in this industry has historically been driven by the introduction of new technologies and the expansion of domestic and international markets. The latter part of the 20th century witnessed the introduction and consumer acceptance of cable television, home video, video games and compact discs. The 1990s witnessed the emergence of additional products and improved delivery systems such as interactive multimedia entertainment software, simulator and virtual reality attractions and fiber optic cable. The beginning of the 21st century has witnessed even greater expansion as the emergence of next-generation technologies and the convergence of platforms have significantly strengthened growth opportunities for television distribution through direct broadcast satellite and digital cable, video games, Internet access and home video.

 

The market is also in transition as digital distribution is growing rapidly and now playing a more important role in the overall market but also creating a new medium. According to PricewaterhouseCoopers Global Entertainment and Media Outlook, the global Entertainment & Media industry is experiencing sustained growth and will increase at a 6.4% compound annual growth rate to $2 trillion by 2011. PricewaterhouseCoopers estimates that digital and mobile spending during the next five years will rise to $153 billion by 2011. The study estimates that within the next five years, more than 40% of the industry growth will be generated through online and wireless technologies and, during the same period, broadband households will grow by 300 million to 540 million subscribers and wireless subscribers will increase from 2.3 billion in 2006 to 3.4 billion in 2011.

 

1


Table of Contents

We will seek to capitalize on the significant experience of Eric J. Watson, our chairman of the board and treasurer, Jonathan J. Ledecky, our president and secretary, and William Morris Agency, LLC, one of our stockholders and an affiliate of John M. Mass, one of our directors, in identifying, acquiring and operating a wide variety of service businesses. William Morris Agency, LLC, which, together with William Morris SPAC Holdings, LLC, we refer to in this prospectus as William Morris, is one of the largest and preeminent diversified talent and literary agency in the world. Founded in 1898, William Morris employs over 750 people specifically focused on the entertainment, media, and publishing industries in offices in New York City, Beverly Hills, Nashville, Miami, London and Shanghai. William Morris represents clients in all segments of the media and entertainment industry, including motion pictures, television, music and personal appearances, Broadway theatre and theatrical touring, book publishing, commercial endorsements, sports marketing, corporate consulting, digital media and video games. We believe we will benefit from the broad range of business relationships, industry expertise and market insight enjoyed by William Morris as well as those of John M. Mass, a member of William Morris and a member of our board of directors. William Morris is also well positioned in the deal flow of the media, entertainment, and publishing industries. William Morris Agency, LLC has entered into a right of first review agreement with us, in which William Morris Agency, LLC has agreed to present, and to allow Mr. Mass to present, any suitable business opportunity to us prior to presenting it to any other entity, including William Morris, subject to certain exceptions described in this prospectus.

 

Eric J. Watson and Jonathan J. Ledecky have together been personally involved in the formation of over 25 companies and such companies have made over 400 acquisitions. In all of these transactions, each of Messrs. Watson and Ledecky was involved, either directly or in a supervisory capacity, in searching for targets, conducting due diligence, negotiating the terms of the acquisitions and consummating such transactions. Mr. Watson has been the chairman of, and interests associated with him own, Cullen Investments Limited, a private investment company which he founded in January 1995. Mr. Watson and his associated interests have a substantial portfolio comprising interests in the fashion, retail, financial services, real estate, infrastructure maintenance, sports and entertainment sectors. Cullen Investments owns Bendon, an international manufacturer and retailer of women’s lingerie whose brands include the licensed Elle Macpherson Intimates and Stella McCartney labels. Another major investment held by interests associated with Mr. Watson is a 50% ownership of the Hanover Group, one of the largest privately owned financial service businesses in New Zealand with operations extending to the United States, the United Kingdom and Australia. Prior to founding Cullen Investments, Mr. Watson was the founding chairman and largest stockholder of Blue Star Group, a retail and distribution group he founded in January 1992.

 

Since March 1999, Mr. Ledecky has served as chairman of Ironbound Partners Fund LLC, a private investment management fund. In October 1994, Mr. Ledecky founded U.S. Office Products and served as its chief executive officer until November 1997 and chairman until June 1998. In February 1997, Mr. Ledecky founded Building One Services Corporation (originally Consolidation Capital Corporation), an entity formed to identify attractive consolidation opportunities which ultimately focused on the facilities management industry. In November 1997, Building One raised $552 million in an initial public offering. Mr. Ledecky served as Building One’s chief executive officer from November 1997 through February 1999 and as its chairman from inception through its February 2000 merger with Group Maintenance America Corporation.

 

Each of Messrs. Watson and Ledecky and Robert B. Hersov and Edward J. Mathias, each of whom is a member of our board of directors, was also an officer and/or director of Endeavor Acquisition Corp., a blank check company formed in July 2005 for the purpose of effecting a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business. Endeavor Acquisition Corp. consummated its initial public offering in December 2005 and raised gross proceeds of approximately $129.3 million at an offering price of $8.00 per unit. In December 2006, Endeavor Acquisition Corp. entered into a definitive agreement for a business combination to acquire American Apparel, Inc. and its affiliated companies. American Apparel is a leading provider of cotton leisure wear geared toward contemporary metropolitan adults and sold through company-owned retail locations and online. Endeavor Acquisition Corp. consummated its business combination with American Apparel on December 12, 2007.

 

2


Table of Contents

Each of Messrs. Watson, Ledecky, Hersov, and Mathias is also an officer and/or director of Victory Acquisition Corp., a blank check company formed in January 2007 for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, one or more operating businesses in any industry other than the franchising, healthcare or financial services industries. Victory Acquisition Corp. consummated its initial public offering in April 2007 and raised gross proceeds of $330 million at an offering price of $10.00 per unit. Until Victory Acquisition Corp. consummates a business combination, each of these individuals will be required to present all business opportunities which are suitable for Victory Acquisition Corp. to Victory Acquisition Corp. prior to presenting them to us.

 

Additionally, each of Messrs. Watson, Ledecky, Hersov and Mathias and each of Jim Gray and Jimmie Lee Solomon, Jr., each a director of ours, is also an officer and/or director of Triplecrown Acquisition Corp., a blank check company formed in June 2007 for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, one or more operating businesses in the financial services industry. Triplecrown Acquisition Corp. consummated its initial public offering in October 2007 and raised gross proceeds of approximately $552 million at an offering price of $10.00 per unit.

 

In connection with our formation, our executive officers and certain of our directors organized Grand Slam Acquisition Corp. and Endeavour International Acquisition Corp. Grand Slam Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with an operating business located in North America in any industry other than the financial services industry or the entertainment, media and/or publishing industry. Endeavour International Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share capital exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more operating businesses located outside of North America in any industry other than the financial services industry or the entertainment, media and/or publishing industry. We believe that conducting these offerings simultaneously will be beneficial to us for a number of reasons, including allowing us to allocate expenses for identifying target businesses between us, Grand Slam Acquisition Corp. and Endeavour International Acquisition Corp. (such as airfare, lodging and other expenses), thereby potentially reducing the cost to each of us. Additionally, if our offering was the only one being conducted at this time and our officers or directors were presented with an opportunity to acquire a target business located outside of our required parameters, they would be forced to simply abandon such opportunity even though it might be very attractive. By conducting these offerings simultaneously with different target parameters, if our officers or directors were to be presented with such an opportunity, they could present such opportunity to either of the other two companies depending on the characteristics of the targets, thereby reducing the likelihood of not being able to pursue an attractive transaction. We believe this will benefit our stockholders as well as those of Grand Slam Acquisition Corp. and Endeavour International Acquisition Corp. Our officers and directors are not required to commit their full time to our affairs, which could create a conflict of interest when allocating their time between our operations and their other commitments, including Grand Slam Acquisition Corp., Endeavour International Acquisition Corp., Triplecrown Acquisition Corp. and Victory Acquisition Corp. This offering and that of Grand Slam Acquisition Corp. and Endeavour International Acquisition Corp. are not contingent upon each other and while the timing of the offerings may coincide, they are not required to do so. Each offering will proceed independently from the other two.

 

The past experience of our management and members of our board of directors does not guarantee that we will be successful in consummating a business combination. There are numerous risks and uncertainties detailed elsewhere in this prospectus that could impact our ability to consummate a business combination outside of the control of such individuals. Furthermore, our management has been involved with companies that have been forced to file for bankruptcy following their involvement with such companies, including U.S. Office Products. The future role of members of our management team, if any, in the target business cannot presently be stated

 

3


Table of Contents

with any certainty. While it is possible that one or more of our officers or directors will remain associated in some capacity with us following a business combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent to a business combination and we do not intend to ensure that our officers and directors will be able to maintain their positions with us following the consummation of a business combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular target business. As a result, we cannot assure you that we will be able to consummate a business combination at all or on terms favorable to us, nor can we guarantee that we will be successful following the consummation of a business combination.

 

Our initial business combination must be with one or more target businesses whose fair market value, individually or collectively, is equal to at least 80% of the balance in the trust account (excluding deferred underwriting discounts and commissions of $20.0 million, or approximately $23.0 million if the underwriters’ over-allotment option is exercised in full) at the time of the signing of a definitive agreement in connection with our initial business combination. This may be accomplished by identifying and acquiring a single business or multiple operating businesses, which may or may not be related, contemporaneously. However, we will always acquire at least a controlling interest in a target business (typically meaning more than 50% of the voting securities of the target business).

 

The target business or businesses that we acquire may have a collective fair market value substantially in excess of 80% of the balance in the trust account (excluding deferred underwriting discounts and commissions) at the time of the signing of a definitive agreement in connection with our initial business combination. In order to consummate such a business combination, we may issue a significant amount of our debt or equity securities to the sellers of such business and/or seek to raise additional funds through a private offering of debt or equity securities. There are no limitations on our ability to incur debt or issue securities in order to consummate a business combination regardless of whether or not we acquire a target business or businesses having a collective fair market value substantially in excess of 80% of the balance in the trust account at the time of the signing of a definitive agreement in connection with our initial business combination. If we issue securities in order to consummate a business combination, our stockholders could end up owning a minority of the combined company’s voting securities (or that of a parent company depending on the structure of the initial business combination) as there is no requirement that our stockholders own a certain percentage of our company after our business combination. Since we have no specific business combination under consideration, we have not entered into any such arrangement to issue our debt or equity securities and have no current intention of doing so.

 

If we are unable to consummate an initial business combination within 24 months from the date of this prospectus (or within 30 months from the date of this prospectus if a definitive agreement has been executed within 24 months from the date of this prospectus and the business combination has not yet been consummated within such 24-month period), we will liquidate and distribute the proceeds held in the trust account to our public stockholders in an amount we expect to be approximately $9.79 per share of common stock held by them (or approximately $9.77 per share if the underwriters exercise their over-allotment option in full), without taking into account any interest earned on such funds.

 

Private Placements

 

Effective October 24, 2007, we issued 14,375,000 units to William Morris, Summit Trust, an affiliate of Eric J. Watson, Jonathan J. Ledecky and Edward J. Mathias, Robert B. Hersov, Jim Gray, John M. Mass and Jimmie Lee Solomon, each a director of ours, for an aggregate of $25,000 in cash, at a purchase price of approximately $0.002 per unit. We refer to the current holders of these units as the “founders” throughout this prospectus. Each of these units includes one share of common stock and one half of one warrant. Each whole warrant entitles the holder to purchase one share of common stock. This includes an aggregate of up to 1,875,000 units that are subject to forfeiture by our founders to the extent that the over-allotment option is not exercised in

 

4


Table of Contents

full by the underwriters. These holders will be required to forfeit to us, at no cost to us, a number of units necessary to maintain their collective 20% ownership interest in our securities after giving effect to the offering and exercise, if any, of the underwriters’ over-allotment option. We refer to these outstanding units, shares of common stock and warrants as the “founders’ units,” “founders’ common stock” and “founders’ warrants” throughout this prospectus.

 

The founders’ units are identical to the units being sold in this offering, except that:

 

   

up to an aggregate of 1,875,000 founders’ units, representing 1,875,000 shares of common stock and 937,500 warrants, are subject to forfeiture by our founders to the extent that the over-allotment option is not exercised in full or in part by the underwriters;

 

   

the founders’ units will be placed in escrow and the founders’ common stock and founders’ warrants are subject to the transfer restrictions and entitled to the registration rights described below;

 

   

the founders’ warrants will become exercisable after the consummation of our initial business combination if and when the last sales price of our common stock exceeds $15.00 per share for any 20 trading days within any 30-trading day period beginning 90 days after the initial business combination;

 

   

the founders’ warrants will be exercisable on a cashless basis at the holder’s election and will not be redeemable by us, in each case, as long as they are held by the founders or their permitted transferees;

 

   

the founders have agreed to vote the founders’ common stock in the same manner as the majority of shares voted by the public stockholders at the special or annual meeting called for the purpose of approving our initial business combination;

 

   

the founders have agreed to vote their founders’ common stock in favor of our dissolution and liquidation in the event that we do not consummate an initial business combination within 24 months or 30 months from the date of this prospectus, as applicable.

 

   

the founders will not be able to exercise conversion rights (as described below) with respect to the founders’ common stock; and

 

   

the founders have agreed to waive their rights to participate in any liquidation distribution with respect to the founders’ common stock if we fail to consummate an initial business combination.

 

In addition, Eric J. Watson, Jonathan J. Ledecky and William Morris have agreed to purchase an aggregate of 5,000,000 warrants at a price of $1.00 per warrant ($5.0 million in the aggregate) in a private placement that will occur simultaneously with the consummation of this offering. The $5.0 million of proceeds from this investment will be added to the proceeds of this offering and will be held in the trust account pending our completion of an initial business combination on the terms described in this prospectus. If we do not complete such a business combination, then the $5.0 million will be part of the liquidating distribution to our public stockholders, and the sponsors’ warrants will expire worthless.

 

The sponsors’ warrants will not be transferable or salable by the purchasers (subject to limited exceptions for transfers to permitted transferees including the permitted transferee agreeing to be bound to such transfer restrictions) until we complete a business combination, and will be exercisable on a cashless basis at the holder’s election and will be non-redeemable by us, in each case, as long as they are held by the purchasers or their permitted transferees. In addition, commencing on the date they become exercisable, the sponsors’ warrants and the underlying shares of common stock are entitled to registration rights under an agreement to be signed on or before the date of this prospectus. With the exception of the terms noted above, the sponsors’ warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering.

 

Our executive offices are located at 970 West Broadway, PMB 402, Jackson, Wyoming 83001, and our telephone number is (307) 633-2831.

 

5


Table of Contents

The Offering

 

In making your decision on whether to invest in our securities, you should take into account not only the backgrounds of the members of our management team, but also the special risks we face as a blank check company and the fact that this offering is not being conducted in compliance with Rule 419 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). You will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. You should carefully consider these and the other risks set forth in the section below entitled “Risk Factors” beginning on page 23 of this prospectus.

 

Securities offered:

   50,000,000 units, each unit consisting of:
    

•  one share of common stock; and

    

•  one half of one warrant.

Trading commencement and separation of
common stock and warrants:

  

The units will begin trading on or promptly after the date of this prospectus. The common stock and warrants may trade separately on the 35th day after the date of this prospectus unless Citigroup Global Markets Inc. determines that an earlier date is acceptable. No fractional warrants will be issued and only whole warrants will trade. In no event will Citigroup Global Markets Inc. allow separate trading of the common stock and warrants until we file an audited balance sheet reflecting our receipt of the gross proceeds of this offering. We will file a Current Report on Form 8-K with the Securities and Exchange Commission, including an audited balance sheet, promptly upon the consummation of this offering, which is anticipated to take place three business days from the date the units commence trading. The audited balance sheet will reflect our receipt of the proceeds from the exercise of the over-allotment option if the over-allotment option is exercised prior to the filing of the Form 8-K. If the over-allotment option is exercised after our initial filing of a Form 8-K, we will file an amendment to the Form 8-K to provide updated financial information to reflect the exercise and consummation of the over-allotment option. We will also include in this Form 8-K, or amendment thereto, or in a subsequent Form 8-K, information indicating if Citigroup Global Markets Inc. has allowed separate trading of the common stock and warrants prior to the 35th day after the date of this prospectus and will issue a press release announcing when such separate trading will begin.

Units:

    

Number outstanding before this offering:

   14,375,000 units1

Number to be outstanding after this offering:

   62,500,000 units2

Common Stock:

    

Number outstanding before this offering:

   14,375,000 shares1

Number to be outstanding after this offering:

   62,500,000 shares2

1

 

This number includes an aggregate of 1,875,000 founders’ units, representing 1,875,000 shares of founders’ common stock and 937,500 founders’ warrants that are subject to forfeiture by our founders if the over-allotment option is not exercised in full by the underwriters. Only a number of founders’ units, shares of founders’ common stock and founders’ warrants necessary for our founders to maintain their collective 20% ownership interest in our securities will be forfeited upon consummation of this offering.

2

 

Assumes the over-allotment option has not been exercised and an aggregate of 1,875,000 founders’ units, representing 1,875,000 shares of founders’ common stock and 937,500 founders’ warrants have been forfeited by our founders.

 

6


Table of Contents

Warrants:

    

Number outstanding before this
offering:

   7,187,500 warrants1

Number to be sold privately
simultaneously with consummation
of this offering:

   5,000,000 warrants

Number to be outstanding after this
offering and private placement:

   36,250,000 warrants2

Exercisability:

   Each whole warrant is exercisable to purchase one share of common stock. Because each unit includes one half of one warrant, holders will need to have two units in order to have at least one warrant. Warrants may be exercised only in increments of one whole warrant.

Exercise price:

   $5.50 per share.

Exercise period:

   The warrants will become exercisable on the later of:
    

•  the completion of our initial business combination, or

    

•  one year from the date of this prospectus;

     provided in each case that we have an effective and current registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the warrants.
     We have agreed to use our best efforts to have an effective registration statement covering the shares of common stock issuable upon exercise of the warrants as of the date the warrants become exercisable and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed.
     The warrants will expire at 5:00 p.m., New York time, five years from the date of this prospectus or earlier upon redemption.
     On the exercise of any warrant, the warrant exercise price will be paid directly to us and not placed in the trust account.

Redemption:

   At any time while the warrants are exercisable and there is an effective and current registration statement covering the shares of
     common stock issuable upon exercise of the warrants, we may redeem the outstanding warrants (except as described below with respect to the sponsors’ warrants):
    

•  in whole and not in part;

    

•  at a price of $.01 per warrant;


1

 

This number includes an aggregate of 937,500 founders’ warrants that are subject to forfeiture by our founders if the over-allotment option is not exercised in full by the underwriters. Only a number of founders’ warrants necessary for our founders to maintain their collective 20% ownership interest in our securities will be forfeited upon consummation of this offering.

2

 

Assumes the over-allotment option has not been exercised and an aggregate of 937,500 founders’ warrants have been forfeited by our founders.

 

7


Table of Contents
    

•  upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and

    

•  if, and only if, the last sale price of our common stock equals or exceeds $15.00 per share for any 20 trading days within a 30 trading day period ending three business days before we send the notice of redemption.

     We will not redeem the warrants unless an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants throughout the 30-day redemption period. The underwriters do not have any consent rights in connection with our exercise of our redemption rights.
     If we call the warrants for redemption, we will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis,” though the public stockholders are not eligible to do so at their own option. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

Reasons for redemption limitations:

   We have established the above conditions to our exercise of redemption rights to provide:
    

•  warrant holders with adequate notice of exercise only after the then-prevailing common stock price is substantially above the warrant exercise price; and

    

•  a sufficient differential between the then-prevailing common stock price and the warrant exercise price so there is a buffer to absorb the market reaction, if any, to our redemption of the warrants.

     If the foregoing conditions are satisfied and we issue a notice of redemption, each warrant holder can exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the common stock may fall below the $15.00 trigger price as well as the $5.50 warrant exercise price after the redemption notice is issued.

Proposed American Stock Exchange symbols for our:

    

Units:

   “         .U”

 

Common stock:

   “         ”

 

8


Table of Contents

Warrants:

   “         .WS”

Founders’ units:

   Effective October 24, 2007, our founders purchased 14,375,000 founders’ units, representing 14,375,000 shares of founders’ common stock and 7,187,500 founders’ warrants, for an aggregate purchase price of $25,000. This includes an aggregate of 1,875,000 founders’ units, representing 1,875,000 shares of common stock and 937,500 warrants, that are subject to forfeiture by our founders to the extent that the over-allotment option is not exercised by the underwriters. These holders will be required to forfeit only a number of founders’ units necessary to maintain their collective 20% ownership interest in our securities after giving effect to the offering and exercise, if any, of the underwriters’ over-allotment option. The founders’ units are identical to the units being sold in this offering, except that:
    

•  up to an aggregate of 1,875,000 founders’ units are subject to forfeiture by our founders to the extent that the over-allotment option is not exercised in full by the underwriters;

    

•  the founders’ units will be placed in escrow and the founders’ common stock and founders’ warrants are subject to the transfer restrictions and entitled to the registration rights described in this prospectus;

    

•  the founders’ warrants will become exercisable after the consummation of our initial business combination if and when the last sales price of our common stock exceeds $15.00 per share for any 20 trading days within any 30-trading day period beginning 90 days after the initial business combination and may be exercised for unregistered shares of common stock if a registration statement relating to the common stock issuable upon exercise of founders’ warrants is not effective and current;

 

•  the founders’ warrants will be exercisable on a cashless basis at the election of the holder and will not be redeemable by us, in each case, as long as they are held by the founders or their permitted transferees;

 

•  the founders have agreed to (i) vote the founders’ common stock in the same manner as the majority of shares voted by the public stockholders in connection with the vote required to (ii) approve our initial business combination and (iii) vote in favor of our dissolution and liquidation in the event that we do not consummate an initial business combination within 24 months or 30 months from the date of this prospectus, as applicable;

 

•  the founders will not be able to exercise conversion rights (as described below) with respect to the founders’ common stock; and

 

•  the founders have agreed to waive their rights to participate in any liquidation distribution with respect to the founders’ common stock if we fail to consummate an initial business combination.

 

9


Table of Contents
     All of the founders’ units will be placed in escrow with Continental Stock Transfer & Trust Company, as escrow agent.
     The founders have agreed, subject to certain exceptions, not to sell or otherwise transfer any of the founders’ units and underlying securities until 180 days after the date of the completion of a business combination or earlier if, subsequent to our business combination, (i) the last sales price of our common stock equals or exceeds $15.25 per share for any 20 trading days within any 30-trading day period commencing 90 days after our initial business combination or (ii) we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property. We refer to such restrictions as the “transfer restrictions” throughout this prospectus. In addition, the founders are entitled to registration rights with respect to the founders’ units under an agreement to be signed on or before the date of this prospectus. The holders of the majority of these shares may elect to exercise these registration rights at any time commencing the earlier of (i) nine months after the consummation of our initial business combination or (ii) the date the founders’ units are released from escrow.

Sponsors’ warrants purchased through private placement:

  

Eric J. Watson, Jonathan J. Ledecky and William Morris have entered into agreements with us to purchase an aggregate of 5,000,000 sponsors’ warrants at a price of $1.00 per warrant ($5.0 million in the aggregate). The purchasers are obligated to purchase the sponsors’ warrants from us simultaneously with the consummation of this offering. The sponsors’ warrants will be purchased separately and not in combination with common stock or in the form of units. The purchase price of the sponsors’ warrants will be added to the proceeds from this offering to be held in the trust account pending the completion of our initial business combination. If we do not complete a business combination that meets the criteria described in this prospectus and are forced to liquidate, then the $5.0 million purchase price of the sponsors’ warrants will become part of the distribution to our public stockholders and the sponsors’ warrants will expire worthless.

     The sponsors’ warrants will not be transferable or salable by the purchasers (subject to limited exceptions including the transferee agreeing to be bound to such transfer restrictions) until we complete a business combination. The sponsors’ warrants will be exercisable on a cashless basis at the election of the holder and will be non-redeemable by us, in each case, so long as they are held by the purchasers or their affiliates. In addition, commencing 90 days after the consummation of our initial business combination, the sponsors’ warrants and the underlying common stock are entitled

 

10


Table of Contents
    to registration rights under an agreement to be signed on or before the date of this prospectus. With the exception of the terms noted above, the sponsors’ warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering.

Offering and sponsors’ warrants private placement proceeds to be held in trust account and amounts payable prior to trust account distribution or liquidation:

 

$489,250,000, or approximately $9.79 per unit ($562,000,000, or approximately $9.77 per unit, if the underwriters’ over-allotment option is exercised in full) of the proceeds of this offering and the private placement of the sponsors’ warrants will be placed in the trust account at JPMorgan Chase NY Bank with Continental Stock Transfer & Trust Company as trustee, pursuant to an agreement to be signed on the date of this prospectus. These proceeds include $20.0 million in deferred underwriting discounts and commissions (or approximately $23.0 million if the underwriters’ over-allotment option is exercised in full). We believe that the inclusion in the trust account of the purchase price of the sponsors’ warrants and the deferred underwriting discounts and commissions is a benefit to our public stockholders because additional proceeds will be available for distribution to them if a liquidation of our company occurs prior to the consummation of our initial business combination. Except as described below, proceeds in the trust account will not be released until the earlier of our consummation of our initial business combination or our liquidation. Unless and until our initial business combination is consummated, proceeds held in the trust account will not be available for our use for any purpose, including the payment of expenses related to (i) this offering, and (ii) the investigation, selection and negotiation of an agreement with one or more target businesses, except that there can be released to us from the trust account (a) interest income earned on the trust account balance to pay our tax obligations and (b) interest income earned of up to $5.0 million, or approximately $5.8 million if the underwriters’ over-allotment option is exercised in full, on the trust account balance to fund our working capital requirements; provided, however, that we will not be allowed to withdraw interest income earned on the trust account for our working capital requirements unless we have sufficient funds available to us to pay our tax obligations on such interest income or otherwise then due at that time. With these exceptions, expenses incurred by us while seeking a business combination may be paid prior to a business combination only from the net proceeds of this offering not held in the trust account (initially, approximately $50,000).

Limited payments to insiders:

  There will be no fees, reimbursements or other cash payments paid or awarded by us or a target business to or earned by our founders, officers, directors or their affiliates prior to, or for any services they render in order to effectuate, the consummation of a business combination (regardless of the type of transaction that it is) other than:
   

•  Repayment of non-interest bearing loans totaling $135,000 in the aggregate made to us by Eric J. Watson and Jonathan J. Ledecky to cover offering expenses; and

 

11


Table of Contents
   

•  Reimbursement for any expenses incident to identifying, investigating and consummating a business combination with one or more target businesses, none of which have been incurred to date. There is no limit on the amount of out-of-pocket expenses that could be incurred; provided, however, that to the extent such out-of-pocket expenses exceed the available proceeds not deposited in the trust account and interest income of up to $5.0 million, or approximately $5.8 million if the underwriters’ over-allotment option is exercised in full, on the balance in the trust account, such out-of-pocket expenses would not be reimbursed by us unless we consummate an initial business combination.

    Our audit committee will review and ratify all reimbursements made to our founders, sponsors, officers, directors or their affiliates, with any interested director abstaining from such review.

All amounts held in the trust account that are not paid to converting stockholders as a result of their shares being converted to cash, released to us in the form of interest income or payable to the underwriters for deferred discounts and commissions will be released to us on closing of our initial business combination:

 

All amounts held in the trust account that are not distributed to public stockholders who exercise their conversion rights (as described below) as their shares are converted to cash or previously released to us as interest income for our working capital requirements and tax obligations will be released on closing of our initial business combination with one or more target businesses, subject to compliance with the conditions to consummating a business combination that are described below. We will use these funds to pay amounts due to any public stockholders who exercise their conversion rights and to pay the underwriters their deferred underwriting discounts and commissions that are equal to 4.0% of the gross proceeds of this offering, or $20.0 million (or approximately $23.0 million if the underwriters’ over-allotment option is exercised in full). Funds released from the trust account to us can be used to pay all or a portion of the purchase price of the business or businesses with which our initial combination occurs. If our initial business combination is paid for using stock or debt securities, we may apply the cash released to us from the trust account to general corporate purposes, including for maintenance or expansion of operations of the acquired businesses, the payment of principal or interest due on indebtedness incurred in consummating our initial business combination or to fund the purchase of other companies or for working capital.

Certificate of Incorporation:

  As discussed below, there are specific provisions in our amended and restated certificate of incorporation that may not be amended prior to our consummation of a business combination, including our

 

12


Table of Contents
    requirements to seek stockholder approval of such a business combination and to allow our stockholders to seek conversion of their shares if they do not approve of such a business combination as well as the related conversion threshold and the fact that such provision may not be amended prior to our consummation of an initial business combination. Accordingly, there is no specific percentage of public stockholders that would allow for such provisions to be amended. While we have been advised that such provisions limiting our ability to amend our certificate of incorporation may not be enforceable under Delaware law, we view these provisions, which are contained in Article Sixth of our amended and restated certificate of incorporation, as obligations to our stockholders and will not take any action to amend or waive these provisions.

Stockholders must approve initial business combination:

 

We will seek stockholder approval before effecting our initial business combination regardless of the type of transaction it is, even if the business combination would not ordinarily require stockholder approval under applicable state law.

    In connection with the vote required to approve our initial business combination, all of our founders, including all of our officers and directors, have agreed to vote the shares of common stock owned by them immediately before this offering in accordance with the majority of the shares of common stock voted by the public stockholders at the meeting called for the purpose of approving our initial business combination. They have also agreed to vote any shares acquired by them in this offering or in the aftermarket in favor of a business combination. Thus, additional purchases of shares of common stock by our founders, including our officers or directors, would likely allow them to exert additional influence over the approval of our initial business combination. The factors that would be considered in making such additional purchases would include consideration of the current trading price of our common stock. Another factor that would be taken into consideration would be that any such additional purchases would likely increase the chances that our initial business combination would be approved. We will proceed with a business combination only if (i) a majority of the shares of common stock voted by the public stockholders are voted in favor of the business combination and (ii) public stockholders owning less than 30% of the shares of common stock sold in this offering exercise their conversion rights described below. We will not increase or decrease the conversion threshold prior to the consummation of our initial business combination. Accordingly, it is our intention in every case to structure and consummate a business combination in which approximately 29.99% of the public stockholders may exercise their conversion rights and the business combination will still go forward.

Conditions to consummating our initial business combination:

 

We will not consummate a business combination with any target business affiliated with any of our officers, directors or founders

 

13


Table of Contents
    including (i) an entity that is either a portfolio company of, or has otherwise received a material financial investment from any private equity fund or investment company (or an affiliate thereof) that is affiliated with such individuals, (ii) an entity in which such individuals or their affiliates are currently passive investors, (iii) an entity in which such individuals or their affiliates are currently officers or directors, or (iv) an entity in which such individuals or their affiliates are currently invested through an investment vehicle controlled by them. Our initial business combination must occur with one or more target businesses that collectively have a fair market value of at least 80% of the balance in the trust account (excluding deferred underwriting discounts and commissions of $20.0 million, or approximately $23.0 million if the underwriters’ over-allotment option is exercised in full) at the time of the signing of a definitive agreement in connection with our initial business combination. If we acquire less than 100% of a target business in our initial business combination, the aggregate fair market value of the portion we acquire must equal at least 80% of the balance in the trust account (excluding deferred underwriting discounts and commissions as described above) at the time of the signing of a definitive agreement in connection with our initial business combination. The fair market value of a portion of a target business will likely be calculated by multiplying the fair market value of the entire business by the percentage of the business we acquire. However, we will always acquire at least a controlling interest of a target business (typically meaning more than 50% of the voting securities of such target business). We may seek to consummate a business combination with an initial target business or businesses with a collective fair market value in excess of 80% of the balance in the trust account at the time of the signing of a definitive agreement in connection with our initial business combination. However, we may need to obtain financing to consummate such a business combination and have not taken any steps to obtain any such financing.
    We will consummate our initial business combination only if a majority of the shares of common stock voted by the public stockholders are voted in favor of our initial business combination and less than 30% of the shares sold in this offering are voted against the business combination and exercise their conversion rights described below. It is important to note that voting against our initial business combination alone will not result in conversion of a stockholder’s shares into a pro rata share of the trust account, which only occurs when the stockholder also exercises the conversion rights described below.

Conversion rights for stockholders
voting to reject our initial business combination:

 

We will not complete any proposed initial business combination in connection with which public stockholders owning 30% or more of the shares included in the units sold in this offering exercise their conversion rights. We will not increase or decrease the conversion threshold prior to the consummation of our initial business

 

14


Table of Contents
    combination. We have set the conversion percentage at 30% in order to reduce the likelihood that a small group of investors holding a block of our stock will be able to stop us from completing a business combination that may otherwise be approved by a large majority of our public stockholders. If our initial business combination is approved and completed, public stockholders voting against our initial business combination will be entitled to convert their shares of common stock into a pro rata share of the aggregate amount then on deposit in the trust account, before payment of deferred underwriting discounts and commissions and including interest earned on their pro rata portion of the trust account, net of interest income on the trust account balance previously released to us to pay our tax obligations and net of interest income of up to $5.0 million, or approximately $5.8 million if the underwriters’ over-allotment option is exercised in full, on the trust account balance previously released to us to fund our working capital requirements. If our initial business combination is not approved or completed for any reason, then public stockholders voting against our initial business combination will not be entitled to convert their shares of common stock into a pro rata share of the aggregate amount then on deposit in the trust account. The founders will not be able to exercise conversion rights with respect to any of our shares that they may acquire prior to, in or after this offering under any circumstances.
    Public stockholders who convert their shares of common stock into a pro rata share of the trust account will be paid their conversion price promptly following the consummation of our initial business combination and will continue to have the right to exercise any warrants they own. The initial per share conversion price is approximately $9.79 per share (or approximately $9.77 per share if the underwriters’ over-allotment option is exercised in full), without taking into account any interest earned on such funds. Since this amount is less than the $10.00 per unit price in this offering and may be lower than the market price of the common stock on the date of conversion, there may be a disincentive on the part of public stockholders to exercise their conversion rights. Because converting stockholders will receive their proportionate share of deferred underwriting compensation and the underwriters will be paid the full amount of the deferred underwriting compensation at the time of closing of our initial business combination, the non-converting stockholders will bear the financial effect of such payments to both the converting stockholders and the underwriters.

Limitations on conversion rights:

  A public stockholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as such term is defined in Section 13(d)(3) of the Securities Act of 1933, as amended) will be restricted from seeking conversion rights with respect to more than 10% of the shares sold in this offering. We will require each public stockholder seeking to exercise conversion rights to certify to us, under penalty of perjury, whether such stockholder is acting in concert or as a group with any other stockholder. Such a public stockholder would still be entitled to vote against a proposed business combination with respect to all shares owned by him or his

 

15


Table of Contents